[1] Nienaber CA, Clough RE. Management of acute aortic dissection. The Lancet. 2015;385:800-11.
[2] Nienaber CA, Clough RE, Sakalihasan N, Suzuki T, Gibbs R, Mussa F, et al. Aortic dissection. Nat Rev Dis Primers. 2016;2:16053.
[3] Evangelista A, Isselbacher EM, Bossone E, Gleason TG, Eusanio MD, Sechtem U, et al. Insights From the International Registry of Acute Aortic Dissection: A 20-Year Experience of Collaborative Clinical Research. Circulation. 2018;137:1846-60.
[4] Zhou Ling, Gong Wenqing, Shang Lei, Zheng Minjuan, Liu Liwen, Xiaodong Z. Perioperative survival rate and relevant risk factors in patients with aortic dissection. Chin J Med Ultrasound(Electronic Edition). 2018;15:935-941.
[5] Wang MJ, Chao A, Huang CH, Tsai CH, Lin FY, Wang SS, et al. Hyperbilirubinemia after cardiac operation. Incidence, risk factors, and clinical significance. The Journal of thoracic and cardiovascular surgery. 1994;108:429-36.
[6] Nishi H, Sakaguchi T, Miyagawa S, Yoshikawa Y, Fukushima S, Saito S, et al. Frequency, risk factors and prognosis of postoperative hyperbilirubinemia after heart valve surgery. Cardiology (Switzerland). 2012;122:12-9.
[7] Hsu RB, Lin FY, Chen RJ, Chou NK, Ko WJ, Chi NH, et al. Incidence, risk factors, and prognosis of postoperative hyperbilirubinemia after heart transplantation. Eur J Cardiothorac Surg. 2007;32:917-22.
[8] An Y, Xiao YB, Zhong QJ. Hyperbilirubinemia after extracorporeal circulation surgery: A recent and prospective study. World Journal of Gastroenterology. 2006;12:6722-6.
[9] Yang L, Li J, Wang G, Zhou H, Fang Z, Shi S, et al. Postoperative liver dysfunction after total arch replacement combined with frozen elephant trunk implantation: incidence, risk factors and outcomes. Interactive cardiovascular and thoracic surgery. 2019;29:930-6.
[10] Kraev AI, Torosoff MT, Fabian T, Clement CM, Perez-Tamayo RA. Postoperative hyperbilirubinemia is an independent predictor of longterm outcomes after cardiopulmonary bypass. Journal of the American College of Surgeons. 2008;206:645-53.
[11] Collins JD, Bassendine MF, Ferner R, Blesovsky A, Murray A, Pearson DT, et al. Incidence and prognostic importance of jaundice after cardiopulmonary bypass surgery. Lancet (London, England). 1983;1:1119-23.
[12] Sharma P, Ananthanarayanan C, Vaidhya N, Malhotra A, Shah K, Sharma R. Hyperbilirubinemia after cardiac surgery: An observational study. Asian Cardiovasc Thorac Ann. 2015;23:1039-43.
[13] Lockey E, McIntyre N, Ross DN, Brookes E, Sturridge MF. Early jaundice after open-heart surgery. Thorax. 1967;22:165-9.
[14] Farag M, Veres G, Szabo G, Ruhparwar A, Karck M, Arif R. Hyperbilirubinaemia after cardiac surgery: the point of no return. ESC heart failure. 2019;6:694-700.
[15] Wang Y, Bellomo R. Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment. Nat Rev Nephrol. 2017;13:697-711.
[16] Michalopoulos A, Alivizatos P, Geroulanos S. Hepatic dysfunction following cardiac surgery: determinants and consequences. Hepato-gastroenterology. 1997;44:779-83.
[17] Wang J, Yu W, Zhai G, Liu N, Sun L, Zhu J. Independent risk factors for postoperative AKI and the impact of the AKI on 30-day postoperative outcomes in patients with type A acute aortic dissection: an updated meta-analysis and meta-regression. Journal of thoracic disease. 2018;10:2590-8.
[18] Zhao H, Pan X, Gong Z, Zheng J, Liu Y, Zhu J, et al. Risk factors for acute kidney injury in overweight patients with acute type A aortic dissection: a retrospective study. Journal of thoracic disease. 2015;7:1385-90.
[19] Zhou H, Wang G, Yang L, Shi S, Li J, Wang M, et al. Acute Kidney Injury After Total Arch Replacement Combined With Frozen Elephant Trunk Implantation: Incidence, Risk Factors, and Outcome. J Cardiothorac Vasc Anesth. 2018;32:2210-7.
[20] Qiu Z, Chen L, Cao H, Zhang G, Xu F, Chen Q. Analysis of risk factors for acute kidney injury after ascending aortic replacement combined with open placement of triple-branched stent graft in type A aortic dissection: a new technique versus the traditional method in a single Chinese center. Medical science monitor : international medical journal of experimental and clinical research. 2015;21:674-80.
[21] Sasabuchi Y, Kimura N, Shiotsuka J, Komuro T, Mouri H, Ohnuma T, et al. Long-Term Survival in Patients With Acute Kidney Injury After Acute Type A Aortic Dissection Repair. Ann Thorac Surg. 2016;102:2003-9.
[22] Luo HY, Hu KJ, Liu ZY, Cheng Y, Zhao Y, Pan S, et al. [Analysis of the risk factors of postoperative renal failure of type A aortic dissection]. Zhonghua wai ke za zhi [Chinese journal of surgery]. 2008;46:1070-2.
[23] Roh GU, Lee JW, Nam SB, Lee J, Choi JR, Shim YH. Incidence and risk factors of acute kidney injury after thoracic aortic surgery for acute dissection. Ann Thorac Surg. 2012;94:766-71.
[24] Xu S, Liu J, Li L, Wu Z, Li J, Liu Y, et al. Cardiopulmonary bypass time is an independent risk factor for acute kidney injury in emergent thoracic aortic surgery: a retrospective cohort study. Journal of cardiothoracic surgery. 2019;14:90.
[25] Ko T, Higashitani M, Sato A, Uemura Y, Norimatsu T, Mahara K, et al. Impact of Acute Kidney Injury on Early to Long-Term Outcomes in Patients Who Underwent Surgery for Type A Acute Aortic Dissection. Am J Cardiol. 2015;116:463-8.
[26] Anil Z. Apaydin SB, Hakan Posacioglu, Fatih Islamoglu,Tanzer Calkavur, Tahir Yagdi, Mustafa Ozbaran and, Yuksel M. Perioperative Risk Factors for Mortality in Patients With Acute Type A Aortic Dissection. Ann Thorac Surg. 2002;74.
[27] Tsai HS, Tsai FC, Chen YC, Wu LS, Chen SW, Chu JJ, et al. Impact of acute kidney injury on one-year survival after surgery for aortic dissection. Ann Thorac Surg. 2012;94:1407-12.
[28] Yuan L, Liao PP, Song HC, Zhou JH, Chu HC, Lyu L. Hyperbilirubinemia Induces Pro-Apoptotic Effects and Aggravates Renal Ischemia Reperfusion Injury. Nephron. 2019;142:40-50.
[29] Barateiro A, Domingues HS, Fernandes A, Relvas JB, Brites D. Rat cerebellar slice cultures exposed to bilirubin evidence reactive gliosis, excitotoxicity and impaired myelinogenesis that is prevented by AMPA and TNF-alpha inhibitors. Molecular neurobiology. 2014;49:424-39.
[30] Komardina E, Yaroustovsky M, Abramyan M, Plyushch M. Prometheus therapy for the treatment of acute liver failure in patients after cardiac surgery. Kardiochir Torakochirurgia Pol. 2017;14:230-5.
[31] Cui J, Zhao H, Yi B, Zeng J, Lu K, Ma D. Dexmedetomidine Attenuates Bilirubin-Induced Lung Alveolar Epithelial Cell Death In Vitro and In Vivo. Crit Care Med. 2015;43:e356-68.
[32] Chu CM, Chang CH, Liaw YF, Hsieh MJ. Jaundice after open heart surgery: a prospective study. Thorax. 1984;39:52-6.
[33] Mundth ED, Keller AR, Austen WG. Progressive hepatic and renal failure associated with low cardiac output following open-heart surgery. The Journal of thoracic and cardiovascular surgery. 1967;53:275-84.
[34] Mitzner SR, Stange J, Klammt S, Risler T, Erley CM, Bader BD, et al. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2000;6:277-86.
[35] Pan KC, McKenzie DP, Pellegrino V, Murphy D, Butt W. The meaning of a high plasma free haemoglobin: retrospective review of the prevalence of haemolysis and circuit thrombosis in an adult ECMO centre over 5 years. Perfusion. 2016;31:223-31.
[36] Toomasian JM, Bartlett RH. Hemolysis and ECMO pumps in the 21st Century. Perfusion. 2011;26:5-6.